| Gilbert Ryan Dominguez, MD | |
|
9850 Genesee Ave, Suite 810, La Jolla, CA 92037-1224 | |
| (858) 450-1212 | |
| (858) 453-9271 |
| Full Name | Gilbert Ryan Dominguez |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 25 Years |
| Location | 9850 Genesee Ave, La Jolla, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275601478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A75306 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Scripps Memorial Hospital La Jolla | La jolla, CA | Hospital |
| Scripps Green Hospital | La jolla, CA | Hospital |
| Entity Name | Temecula Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922333723 PECOS PAC ID: 8022394071 Enrollment ID: O20170406000537 |
News Archive
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration in cardiovascular diseases, central nervous system injuries, ophthalmic indications and dermal wounds, announced today that it intends to offer units consisting of shares of its common stock and warrants to purchase shares of its common stock in a public offering.
The Los Angeles Times: "The abrupt resignation last month of Anthem Blue Cross' president is offering a glimpse of an internal struggle that has roiled California's largest for-profit health insurer for months. Leslie Margolin was the public face of Anthem this year when it sought to raise individual insurance rates as much as 39%.
Teva Pharmaceutical Industries Ltd. today announced positive results from a study assessing a new lower-volume injection of Copaxone® (glatiramer acetate) containing the currently approved dose in half the injection volume.
Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the two companies have formed an exclusive collaboration focused on the discovery and development of novel lipid nanoparticles, known as small lipid nanoparticles ("sLNPs"), using microfluidics technology.
Researchers from the Chronic Renal Insufficiency Cohort study are embarking on another five years of work to identify risk factors for progression of early stage chronic kidney disease, better understand the importance of reduced kidney function in older persons, and learn what role CKD may play in other illnesses that require hospitalization. CRIC is supported by the National Institutes of Health.
› Verified 3 days ago
| Entity Name | Twg Medical Cas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174211403 PECOS PAC ID: 6800254806 Enrollment ID: O20230623001289 |
News Archive
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration in cardiovascular diseases, central nervous system injuries, ophthalmic indications and dermal wounds, announced today that it intends to offer units consisting of shares of its common stock and warrants to purchase shares of its common stock in a public offering.
The Los Angeles Times: "The abrupt resignation last month of Anthem Blue Cross' president is offering a glimpse of an internal struggle that has roiled California's largest for-profit health insurer for months. Leslie Margolin was the public face of Anthem this year when it sought to raise individual insurance rates as much as 39%.
Teva Pharmaceutical Industries Ltd. today announced positive results from a study assessing a new lower-volume injection of Copaxone® (glatiramer acetate) containing the currently approved dose in half the injection volume.
Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the two companies have formed an exclusive collaboration focused on the discovery and development of novel lipid nanoparticles, known as small lipid nanoparticles ("sLNPs"), using microfluidics technology.
Researchers from the Chronic Renal Insufficiency Cohort study are embarking on another five years of work to identify risk factors for progression of early stage chronic kidney disease, better understand the importance of reduced kidney function in older persons, and learn what role CKD may play in other illnesses that require hospitalization. CRIC is supported by the National Institutes of Health.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gilbert Ryan Dominguez, MD 9850 Genesee Ave, Suite 810, La Jolla, CA 92037-1224 Ph: (858) 450-1212 | Gilbert Ryan Dominguez, MD 9850 Genesee Ave, Suite 810, La Jolla, CA 92037-1224 Ph: (858) 450-1212 |
News Archive
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration in cardiovascular diseases, central nervous system injuries, ophthalmic indications and dermal wounds, announced today that it intends to offer units consisting of shares of its common stock and warrants to purchase shares of its common stock in a public offering.
The Los Angeles Times: "The abrupt resignation last month of Anthem Blue Cross' president is offering a glimpse of an internal struggle that has roiled California's largest for-profit health insurer for months. Leslie Margolin was the public face of Anthem this year when it sought to raise individual insurance rates as much as 39%.
Teva Pharmaceutical Industries Ltd. today announced positive results from a study assessing a new lower-volume injection of Copaxone® (glatiramer acetate) containing the currently approved dose in half the injection volume.
Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the two companies have formed an exclusive collaboration focused on the discovery and development of novel lipid nanoparticles, known as small lipid nanoparticles ("sLNPs"), using microfluidics technology.
Researchers from the Chronic Renal Insufficiency Cohort study are embarking on another five years of work to identify risk factors for progression of early stage chronic kidney disease, better understand the importance of reduced kidney function in older persons, and learn what role CKD may play in other illnesses that require hospitalization. CRIC is supported by the National Institutes of Health.
› Verified 3 days ago
Alexa Chavez, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 9300 Campus Point Dr # Mc7196, La Jolla, CA 92037 Phone: 858-657-7539 | |
Dr. Stacie Sanmiguel, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9500 Gilman Dr # Mc-0039, La Jolla, CA 92093 Phone: 858-822-4757 Fax: 858-534-7545 | |
Dr. James Donald Dibdin, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 505 Coast Blvd South # 408, La Jolla, CA 92037 Phone: 858-459-7788 | |
Dr. Rhodaline Tootell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, Ste 320, La Jolla, CA 92037 Phone: 858-554-1212 | |
Dr. Seymour Myers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave Ste 320, La Jolla, CA 92037 Phone: 858-554-1212 Fax: 858-554-1222 | |
Dr. Nicholas Canelo, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave Ste 320, La Jolla, CA 92037 Phone: 858-554-1212 | |
Dr. Rhona H Fink, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 9898 Genesee Ave, La Jolla, CA 92037 Phone: 858-824-5383 Fax: 858-964-3125 |